Assay Detail
Functional
CHEMBL4254890
Review assay metadata, readout intent, target linkage, and publication context from the same page.
Cytotoxicity against human HT-29 cells assessed as inhibition of cell viability after 72 hrs by MTT assay
9
Total Activities
9
Compounds Tested
1
Activity Types
0
Assay Parameters
Assay Information
| Assay Type | Functional |
| Organism | Homo sapiens |
| Cell Type | HT-29 |
| Confidence | 1 — Organism |
| Curated By | Intermediate |
Publication
Synthesis, anticancer activity and mechanism of action of new thiazole derivatives.
Activity Statistics
| Type | Count | Avg pChEMBL | Best pChEMBL |
|---|---|---|---|
| IC50 | 9 | 4.99 | 6.16 |
Compounds Tested
| Compound | Name | Phase | Activities | Best pChEMBL |
|---|---|---|---|---|
| CHEMBL53463 | DOXORUBICIN | 4.0 | 1 | 6.16 |
| CHEMBL4293246 | — | — | 1 | 5.30 |
| CHEMBL2369206 | — | — | 1 | 5.04 |
| CHEMBL4279709 | — | — | 1 | 4.95 |
| CHEMBL4286552 | — | — | 1 | 4.91 |
| CHEMBL4287619 | — | — | 1 | 4.64 |
| CHEMBL4284233 | — | — | 1 | 4.62 |
| CHEMBL4286224 | — | — | 1 | 4.32 |
| CHEMBL4294855 | — | — | 1 | - |
Activity Data
| Compound | Name | Type | Rel. | Value | Units | pChEMBL |
|---|---|---|---|---|---|---|
| CHEMBL53463 | DOXORUBICIN | IC50 | = | 690.0 | nM | 6.16 |
| CHEMBL4293246 | — | IC50 | = | 5060.0 | nM | 5.30 |
| CHEMBL2369206 | — | IC50 | = | 9020.0 | nM | 5.04 |
| CHEMBL4279709 | — | IC50 | = | 11150.0 | nM | 4.95 |
| CHEMBL4286552 | — | IC50 | = | 12210.0 | nM | 4.91 |
| CHEMBL4287619 | — | IC50 | = | 22740.0 | nM | 4.64 |
| CHEMBL4284233 | — | IC50 | = | 23890.0 | nM | 4.62 |
| CHEMBL4286224 | — | IC50 | = | 47770.0 | nM | 4.32 |
| CHEMBL4294855 | — | IC50 | > | 63560.0 | nM | - |